Dermatologicals

Dermatologicals is projected to continue to post strong retail current value growth in 2023. Increasing retail value sales have, on the one hand, been influenced by rising unit prices, amid a highly inflationary climate. In addition, hair loss…

After recording strong growth in 2022, sales of many dermatologicals in 2023 are weakening. Declining disposable incomes due to elevated inflation and higher interest rates are eroding the interest of Spaniards in spending on perceived non-essential…

In 2023, dermatologicals is set to return to solid current value growth, although performances are expected to vary widely across categories. For instance, hair loss treatments is expected to continue to benefit from consumers’ perception of their…

International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain…

Dermatologicals is set to register positive growth in current value and retail volume terms in 2023. With the WHO declaring the pandemic to be over in May 2023, there has been an increase in socialisation and physical contact between people which has…

Most types of dermatologicals saw an upward sales trend in retail volume terms in 2023, although the rate of expansion was lower than that seen in many other consumer health categories. Despite the increasing incidence of diagnosed skin diseases…

Healthy growth in dermatologicals is stemming from launches of value-added products. There was a pause on most new product development activity during the COVID-19 crisis, but with the end of the pandemic, products that had been held back have been…

Sales of dermatologicals have benefited from the return to normal activities following the lifting of pandemic-related restrictions. Consumers are out in public again and socialising and are consequently looking to treat any conditions to ensure thy…

Affordability is a key factor within dermatologicals, with some products on the landscape being very expensive for the average consumer. As such, people need to find products within their budget, allowing them to address their specific skin issues.…

Despite another positive performance by dermatologicals in 2023, the category is recording significantly slower growth rates compared to 2022. The dynamic growth in 2022 was due to the fact that after the lifting of restrictions in Vietnam, local…

2022 brought closure to many of the lasting pandemic-driven behaviours impacting dermatologicals, such as mask-wearing, an extreme focus on sanitisation, and remaining social distancing practices in large settings. Yet, the year also presented new…

Hair loss treatments in the United Arab Emirates has been experiencing increased fragmentation, due to the emergence of numerous new entrants, with the value share of the smallest players, included under “others” set to rise above 50% for the first…

In general, dermatologicals was largely unaffected by the Coronavirus (COVID-19) pandemic. Most categories of dermatologicals continued to see retail volume growth in 2020, many of them at a similar rate to 2019. There are a number of underlying…

Dermatologicals continued to record positive value growth in current price terms over the course of 2023 as the essential nature of many of these products for those experiencing moderate skin health issues ensured that demand remained relatively…

Dermatologicals has performed impressively in 2023, with all categories set to record stronger volume growth rates than in 2022. Demand for some product types has picked up as the increased levels of social contact brought about by the easing of the…

Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…

The incidence of head lice is rising back to normal levels in 2023 as children circulate freely in schools and at social gatherings, and kids play close together. With retail volume sales back to pre-pandemic levels in 2022, demand for…

Dermatologicals is seeing solid current value growth in 2023, driven in part by higher retail prices. The category is benefiting from a return to normal daily lifestyles following the COVID-19 pandemic. Consumers’ skin is being more exposed to…

Dermatologicals has seen demand weaken in the post-pandemic period. While certain COVID-19 related habits, such as the use of hand sanitisers, remain relevant and people in Greece continue to use them much more than they did in the past, this is a…

Value growth for dermatologicals continues to slow in 2023 as local consumers prioritise the treatment of other health concerns. According to a study led by the French Society of Dermatology (SFD), one in three French citizen suffers from a skin…